Former CFO of SBT Venture Capital Andrew Martin Joins Fineqia's Advisory Board

VANCOUVER, British Columbia, April 6, 2017 /PRNewswire/ --





Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTCPink: FNQQF) today welcomes the Chief Financial Officer (CFO) of SBT Venture Capital, Andrew Martin, to its board of advisors. 

Andrew has been in the 'deal business' for over 30 years. He was a project finance and leverage buyout banker with Chemical Bank, subsequently transitioning to the bank's captive private equity business where he successfully led co-investments in over 20 transactions as well as profitable exits from portfolio companies.

Andrew has since managed a HINWI pledge fund, successfully negotiated and documented a $300m TMT fund with a large pension fund and supra national institution and advised companies on acquisitions/disposals, and raising equity and debt finance. More recently he has advised early stage companies in a range of sectors and was a CFO of Sberbank's Fintech early stage fund - SBT Venture Capital until 2015.

"We are very excited that Andrew is joining our board of advisors," said Fineqia's Chairman Martin Graham. "His wealth of experience in advising companies on raising equity and debt finance will prove invaluable in making our platform a success."

Fineqia's board of advisors and its members are not officers or directors of the company.

About Fineqia International Inc. 

Fineqia's business model is to provide an online platform and associated services for the placement of debt and equity securities, initially in the UK. The platform will transparently highlight the risks and objectively outline opportunities involved.  For more information, visit http://www.fineqia.com.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATORY SERVICE PROVIDER HAS REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

FORWARD-LOOKING STATEMENTS 

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to complete the Change of Business, failure to obtain sufficient financing, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made and except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement.

Karolina Komarnicka, Chief Marketing Officer, T: +1(778)654-2324, E: info@fineqia.com, W: http://www.fineqia.com


Fineqia International Inc.

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234